Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
858 0 |
SM ISO690:2012 ANTOCI, Vasilichia, CUCU, Dumitrela, ZBANCIOC, Gheorghita N., MOLDOVEANU, Costel, MANGALAGIU, Violeta, AMĂRIUCĂI-MANTU, Dorina, ARICU, Aculina, MANGALAGIU, Ionel. Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity. In: Future Medicinal Chemistry, 2020, nr. 3(12), pp. 207-222. ISSN 1756-8919. DOI: https://doi.org/10.4155/fmc-2019-0063 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Future Medicinal Chemistry | |||||||
Numărul 3(12) / 2020 / ISSN 1756-8919 /ISSNe 1756-8927 | |||||||
|
|||||||
DOI: https://doi.org/10.4155/fmc-2019-0063 | |||||||
Pag. 207-222 | |||||||
|
|||||||
Rezumat | |||||||
Aim: Over the last decades, few significant achievements have been made in tuberculosis (TB) therapy. As a result, there is an urgent need for new anti-TB drugs. Results: Two new classes of bis-(imidazole/benzimidazole)-pyridine derivatives were designed, synthesized and evaluated for their antimycobacterial activity. Conclusion: The synthesis is efficient and straightforward, involving only two successive N-alkylations. The anti-TB assay reveal that our compounds have an excellent anti-TB activity against both replicating and nonreplicating Mtb, are not cytotoxic, exhibited a very good intracellular activity and are active against drug-resistant Mtb strains, some compounds have a bactericidal mechanism. The absorption, distribution, metabolism, excretion and toxicity studies performed for one compound are promising, indicating that it is a good candidate for a future drug. |
|||||||
Cuvinte-cheie ADMET, antimycobacterial, bis-(imidazole/benzimidazole)-pyridine, MBC, MIC |
|||||||
|
Crossref XML Export
<?xml version='1.0' encoding='utf-8'?> <doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'> <head> <doi_batch_id>ibn-97459</doi_batch_id> <timestamp>1711696160</timestamp> <depositor> <depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name> <email_address>idsi@asm.md</email_address> </depositor> </head> <body> <journal> <journal_metadata> <full_title>Future Medicinal Chemistry</full_title> <issn media_type='print'>17568919</issn> </journal_metadata> <journal_issue> <publication_date media_type='print'> <year>2020</year> </publication_date> <issue>3(12)</issue> </journal_issue> <journal_article publication_type='full_text'><titles> <title>Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity</title> </titles> <contributors> <person_name sequence='first' contributor_role='author'> <given_name>Vasilichia</given_name> <surname>Antoci</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Dumitrela</given_name> <surname>Cucu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Gheorghita N.</given_name> <surname>Zbancioc</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Costel</given_name> <surname>Moldoveanu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Violeta</given_name> <surname>Mangalagiu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Dorina</given_name> <surname>Amăriucăi-Mantu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Aculina</given_name> <surname>Arîcu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Ionel</given_name> <surname>Mangalagiu</surname> </person_name> </contributors> <publication_date media_type='print'> <year>2020</year> </publication_date> <pages> <first_page>207</first_page> <last_page>222</last_page> </pages> <doi_data> <doi>10.4155/fmc-2019-0063</doi> <resource>http://www.crossref.org/</resource> </doi_data> </journal_article> </journal> </body> </doi_batch>